Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q4 FY26 Earnings Presentation
35 slides from Neogen Chemicals's earnings presentation, May 17, 2026
Slide 1: Exchange filing cover letter for earnings presentation
May 17, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Floor 25, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Kala Ghoda, Fort Bandra Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai – 400 051 Scrip Code No: 542665 Comp
Slide 2: Capitalising on Opportunities, Rising in Strength – Q4 FY26 Earnings Presentation
‘Capitalising on Opportunities Rising in Strength’ Q4 FY26 Earnings Presentation May 2026
Slide 3: Safe Harbor
Safe Harbor Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ ma
Slide 4: Table of Contents
Table of Contents 01 02 03 01 02 03 Q4 & FY26 Financial Introduction to Industry Overview: Performance & Neogen Chemicals Lithium-Ion Batteries Expansion Initiatives 04 05 06 04 05 06 Way Forward Sustainability & Contact Us CSR Initiatives
Slide 5: Q4 & FY26 Financial Performance & Expansion Initiatives
Q4 & FY26 Financial Performance & Expansion Initiatives
Slide 6: Performance Highlights – Q4 & FY26
Performance Highlights – Q4 & FY26 Q4 FY26 Revenue break-up** INR in crore Standalone Consolidated 71% Q4 FY26 FY26 Q4 FY26 FY26 Revenues 22% 249 11% 855 22% 247 11% 862 29% Domestic *Exports Gross Profit 10% 105 9% 382 15% 110 12% 396 *Including deemed exports EBITDA 10% 45 3% 151 21% 44 1% 137 79%
Slide 7: Financial Summary – Q4 FY26
Financial Summary – Q4 FY26 Standalone Consolidated Standalone Consolidated Standalone Consolidated REVENUE EBITDA PAT INR in crore INR in crore INR in crore 44 11 45 249 247 41 15 204 203 36 5 2 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 • Delive
Slide 8: Revenue break-up – Q4 & FY26 (consolidated)
Revenue break-up – Q4 & FY26 (consolidated) Organic Chemicals Inorganic Chemicals 53 181 194 22 Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 734 128 666 112 FY25 FY26 FY25 FY26 INR in crore 7
Slide 9: Financial Table – Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) Particulars (INR In crore) Q4 FY26 Q4 FY25 Growth (%) FY26 FY25 Growth (%) Revenue 248.6 203.8 22% 855.5 773.7 11% Expenditure 203.3 162.6 25% 704.2 626.5 12% EBITDA 45.4 41.2 10% 151.3 147.1 3% EBITDA Margins 18.3% 20.2% -195 bps 17.7% 19.0% -1
Slide 10: Financial Table – Profit & Loss Statement (Consolidated)
Financial Table – Profit & Loss Statement (Consolidated) Particulars (INR In crore) Q4 FY26 Q4 FY25 Growth (%) FY26 FY25 Growth (%) Revenue 246.6 202.8 22% 862.0 777.6 11% Expenditure 202.7 166.4 22% 724.7 641.2 13% EBITDA 43.9 36.4 21% 137.3 136.3 1% EBITDA Margins 17.8% 17.9% -13 bps 15.9% 17.5% -
Slide 11: Balance Sheet Snapshot (Consolidated)
Balance Sheet Snapshot (Consolidated) Particulars (Rs. In crore) Mar 31, 2026 Mar 31, 2025 Assets • Standalone: Total Debt at INR 671 crore in Non-Current Assets 1,509 747 FY26; Net Debt at INR 641 crore Current Assets 1,393 1,000 • Consolidated: Total Debt at INR 1,330 crore in FY26; Net Debt at IN
Slide 12: Key Updates – Q4 FY26 (Neogen Chemicals)
Key Updates – Q4 FY26 (Neogen Chemicals) Capital Infusion • Board approved a preferential allotment of 10 lakh equity shares • Cumulative on-account insurance to promoter group entity, claim received till date stands at aggregating to INR 161 crore INR 140 crore and salvage realization of INR 7 cror
Slide 13: Update on various expansion initiatives: Neogen Ionics Proposed Manufacturing Setup
Update on various expansion initiatives Neogen Ionics Proposed Manufacturing Setup Manufacturing locations Land Area Year Planned Capacities Electrolyte Lithium Electrolyte Salts & Additives FY25 2,000 MT 400 MT Dahej SEZ 6,455 m2 FY26 - 1,100 MT FY27 - 1,000 MT Pakhajan, Dahej PCPIR (New site) 264,
Slide 14: Update on Battery Chemicals (Neogen Ionics)
Update on Battery Chemicals (Neogen Ionics) Revised Timeline & Capex Pakhajan Greenfield Project • Neogen Ionics has revised the project timelines and capital outlay for its Dahej • Commercial manufacturing remains on track for Electrolytes (H1 FY27) and Electrolyte Salts Phase 1 and Pakhajan Phase
Slide 15: Management Commentary – Dr. Harin Kanani
Management Commentary Dr. Harin Kanani Managing Director Commenting on the performance, Dr. Harin Kanani, Managing Director, at Neogen Chemicals said: “Demonstrating strong operational resilience, our Q4 & FY26 performance was robust against a challenging geopolitical backdrop. Growth was driven by
Slide 16: Historical Financial Trends (Consolidated)
Historical Financial Trends (Consolidated) Net Revenue from Operations* (INR crore) EBITDA (INR crore) Margin (%) CAGR: 21% 136 160 19.1% 16.3% 137 25.0% 862 140 17.8% 110 1000 900 778 112 20.0% 686 691 120 800 700 487 100 87 15.0% 600 65 17.5% 80 500 336 15.9% 15.9% 10.0% 60 400 300 40 5.0% 200 20
Slide 17: Seasonal Variance Factors
Seasonal Variance Factors Neogen’s business has Demand for Demand from the Consequently, some seasonal drivers, Lithium-based agrochemicals segment investors are urged to due to which the chemicals tends to be is linked to the crop compare financial Company tends to strong in Q4 as demand cycle and
Slide 18: Introduction to Neogen Chemicals
Introduction to Neogen Chemicals
Slide 19: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 4 Manufacturing Sites + ISO 9001:2015, ISO 258 905 816 21% 2 R&D Facilities 14001:2015 & ISO 45001:2018 Products developed Infrastructure Employees (of Manufacturing units certified on Net worth - FY26 5-year Revenue by in-house R&D which 14% of Quality & SHE managemen
Slide 20: Evolution of Neogen Chemicals
Evolution of Neogen Chemicals 1970’s to 1991 Pre-Neogen 1991 to 2016 Site I 2016 to 2019 Site I & II 2020 to 2024 Multiple Sites ● Mr. HT Kanani is a Chemical ● ‘Neogen Chemicals’ ● Acquired Solaris ChemTech ● Doubled Inorganic Chemicals Engineer from IIT Bombay. His commenced business Industries’ B
Slide 21: Milestones
Milestones Leading manufacturer of Bromine and Lithium-based specialty chemicals since 1989 Started manufacturing Raised INR 132 crore Increased Organic Approved Merger of Buli Promoter infused speciality bromine through initial public Chemicals reactor Chemicals with Neogen INR 161 crore compounds
Slide 22: Business Overview
Business Overview Organic Chemicals End User Industries Bromine Organolithium Advanced Custom Synthesis & Compounds N Butyl Lithium and Intermediates Contract Organic compounds other organolithium Combining Manufacturing containing bromine, products using bromination with Products developed chlorine
Slide 23: Unique value-proposition
Unique value-proposition Experienced Board of Directors Specialised Business State-of-the-art Model with High Entry Barriers Manufacturing Facilities Established Excellent R&D Relationship with Suppliers Capabilities Enduring Customer Innovative Relationships Product Portfolio 22
Slide 24: Experienced Leadership Team
Experienced Leadership Team ● Holds a bachelor’s degree in commerce with Honours Mr. Shyamsunder from the University of Delhi Dr. Harin Kanani Mr. TCN Sai Krishnan Mr. Gopikrishnan Sarathy Upadhyay ● Rich experience of over 35 years in the Specialty Chemical Industry Managing Director Whole time Dir
Slide 25: Large Manufacturing Infrastructure – Neogen Chemicals
Large Manufacturing Infrastructure – Neogen Chemicals Strong Manufacturing Infrastructure Factory Land Area Land Utilisation Capacity Certifications of Manufacturing Facilities Organic Chemicals Inorganic Chemicals (Reactor capacity) (Tonnage) ISO 9001:2015 from Bureau Veritas Certification Mahape (
Slide 26: Driving Innovation Through R&D
Driving Innovation Through R&D 1 1 2 3 4 5 Established two 123-member Focus on R&D to MD actively Post commissioning R&D units dedicated R&D drive sustained involved and of dedicated R&D team, including growth; to spend significant units in 2001, the 11 Ph. D. continue to deploy time overseeing prod
Slide 27: Key Export Geographies
Key Export Geographies Europe China Korea Export sales of 29% USA Japan in FY26 Middle East 26
Slide 28: Industry Overview: Lithium-ion Batteries
Industry Overview Lithium-ion Batteries
Slide 29: Strong Opportunities in Lithium Battery Sector - India
Strong Opportunities in Lithium Battery Sector - India ● Government’s PLI scheme: Strong demand for locally manufactured batteries is expected to catalyse the growth of India's EV ecosystem o Target Incentive Outlay of INR 18,100 crore o Manufacturing capacity of 50 Gwh of ACC o 60% of Battery Mater
Slide 30: Strong Opportunities in Lithium Battery Sector - Global
Strong Opportunities in Lithium Battery Sector - Global Demand Estimates for the Global Market (By 2030) Estimated Battery requirement (GWh) Estimated Electrolyte demand (KT) Estimated Lithium Salt demand (KT) 3,500 3,500 400 350 3,000 3,000 300 141 1,125 2,500 2,500 2,000 1,500 2,000 250 366 200 1,
Slide 31: Way Forward
Way Forward Expand capabilities in adjacent high-end complex chemistries Enhance focus on CSM & Deep inroads in the Advanced Intermediates Battery Materials through portfolio expansion segment Augment the Leverage strong R&D capacities of Organic expertise to introduce and Inorganic Chemicals innova
Slide 32: Sustainability: Driving Value through ESG Excellence
Sustainability: Driving Value through ESG Excellence Strategic ESG Integration for Sustainable Growth Clean Energy Robust Ethical Strengthening Focus Oversight Foundation Corporate Governance The upcoming Dahej ESG risks are formally The Board has approved Aligned with best Greenfield project is int
Slide 33: CSR Approach: Focusing On The Greater Good
CSR Approach: Focusing On The Greater Good Shaping an Inclusive and Sustainable Future Rs. 45.72 Lakh Education Rs. 8.88 Lakh CSR Rs. 37.81 Lakh Healthcare Focus Water Conservation Areas & Natural Resource (FY25) Management Rs. 9.14 Lakh Rs. 26.84 Lakh Women Environment Empowerment Securing the EcoV
Slide 34: Contact Us
Contact Us About Neogen Chemicals Limited Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Code: 542665) is India’s one of the leading manufacturers of Bromine-based and Lithium-based specialty chemicals. Its specialty chemicals product offerings comprise of Organic as well as Inor
Slide 35: Thank You
NE Nee ALS LTD f 7 xX Thank You